Mylan's Levaquin Appeal Shot Down By Federal Circuit
In a victory for Johnson & Johnson, the U.S. Court of Appeals for the Federal Circuit affirmed a lower court's ruling preventing drug maker Mylan Laboratories Inc. from duplicating its lucrative...To view the full article, register now.
Already a subscriber? Click here to view full article